Categories: Health

Financire de Tubize – 2025 half-year financial report

 | Source: Financière de Tubize SA

Half-year financial report 2025
Regulated information 2 August 2025

The board of directors of Financière de Tubize has established the 2025 half-year report. This report is available on the website www.financiere-tubize.be.

  • Profit for the first half of 2025: € 95.6 million (€ 92.9 million in 2024, + 2.8%),
  • Dividend received from UCB: € 98.1 million (€ 1.39 per share, an increase of 2.2% compared to the previous year),
  • 2024 Dividend paid to Financière de Tubize’s shareholders in 2025 of € 46.3 million (€ 1.04 per share, an increase of 7.22% compared to the previous year),
  • Acquisition, in 2025, of 24,487 UCB shares, for a total amount of € 4.37 million, at an average price of € 178.3. Our stake in UCB has increased from 36.27% on 31 December 2024 to 36,28% on 30 June 2025,
  • Decrease of outstanding bank borrowings from € 41.3 million at 31 December 2024 to € nil at 30 June 2025.
GlobeNews Wire

Recent Posts

RCKT Deadline: Rosen Law Firm Urges Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights

NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, reminds investors that a…

52 minutes ago

CORRECTING and REPLACING Berkshire Hathaway Inc. News Release

OMAHA, Neb.--(BUSINESS WIRE)--First paragraph under second table, second sentence should read: At June 30, 2025,…

52 minutes ago

Shell completes sale of interest in Colonial Enterprises Inc. to Brookfield subsidiary

HOUSTON, July 31, 2025 /PRNewswire/ -- Shell Midstream Operating LLC (SMUS), a subsidiary of Shell…

54 minutes ago

IBM Report: 13% Of Organizations Reported Breaches Of AI Models Or Applications, 97% Of Which Reported Lacking Proper AI Access Controls

U.S. breach costs rise to $10.22 million, despite the global average cost of a breach…

54 minutes ago

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

August 01, 2025 17:06 ET  | Source: Taysha Gene Therapies, Inc. DALLAS, Aug. 01, 2025…

10 hours ago

Kia Announces July 2025 Global Sales Results

July 2025 global sales of 262,705 units, up 0.3% Y/yOutside of Korea, Kia sold 217,188…

10 hours ago